Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized Placebo Controlled Study to Evaluate the Effect of BioK+ 50B® on Glycemic Control in a Type 2 Diabetes Population

NCT03239366 is registered in ClinicalTrials.gov with Bio-K Plus International Inc. as lead sponsor.

NCT NCT03239366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03239366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized Placebo Controlled Study to Evaluate the Effect of BioK+ 50B® on Glycemic Control in a Type 2 Diabetes Population
Lead sponsor
Bio-K Plus International Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
September 6, 2017
Completion date
June 30, 2019
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type2 diabetes